ストックスクリーナーアプリを入手
1.09
5.22%
-0.06
アフターアワーズ：
1.13
0.04
+3.67%
前日終値:
$1.15
開ける：
$1.13
24時間の取引高:
145.90K
Relative Volume:
0.02
時価総額：
$6.35M
収益：
$4.75M
当期純損益:
$-7.83M
株価収益率:
5.0069
EPS:
0.2177
ネットキャッシュフロー:
$-7.24M
1週間 パフォーマンス:
-12.10%
1か月 パフォーマンス:
-19.85%
6か月 パフォーマンス:
+85.82%
1年 パフォーマンス:
+45.33%
1日の値動き範囲:
$1.09
$1.14
1週間の範囲:
$1.09
$1.3097
52週間の値動き範囲:
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
名前
Novabay Pharmaceuticals Inc
セクター
電話
510-899-8800
住所
2000 Powell Street, Suite 1150, Emeryville, CA
NBY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.09 | 6.91M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-09-18 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-07-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-15 | 繰り返されました | Laidlaw | Buy |
| 2017-06-05 | 開始されました | ROTH Capital | Buy |
| 2017-03-27 | 開始されました | Laidlaw | Buy |
| 2017-02-06 | 開始されました | Rodman & Renshaw | Buy |
| 2016-03-07 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-12-14 | 繰り返されました | Maxim Group | Buy |
| 2015-04-30 | 再開されました | Maxim Group | Buy |
| 2013-03-06 | 開始されました | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 開始されました | Dawson James | Speculative Buy |
すべてを表示
Novabay Pharmaceuticals Inc (NBY) 最新ニュース
Will NovaBay Pharmaceuticals Inc. (B9P0) stock announce a stock splitJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
Will NovaBay Pharmaceuticals Inc. stock recover faster than industry2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - newser.com
Why NovaBay Pharmaceuticals Inc. stock fits value portfoliosRate Cut & Safe Capital Growth Stock Tips - newser.com
How NovaBay Pharmaceuticals Inc. stock performs in interest rate cycles2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Will NovaBay Pharmaceuticals Inc. stock benefit from commodity pricesPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com
NovaBay Pharmaceuticals Inc. stock trendline breakdown2025 Price Momentum & Fast Momentum Entry Tips - newser.com
Price momentum metrics for NovaBay Pharmaceuticals Inc. explained2025 Volatility Report & Intraday High Probability Alerts - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock benefit from commodity supercycleQuarterly Profit Review & AI Based Buy and Sell Signals - newser.com
Why analysts recommend NovaBay Pharmaceuticals Inc. (B9P0) stockJuly 2025 Breakouts & Real-Time Volume Analysis - newser.com
How NovaBay Pharmaceuticals Inc. stock moves on employment dataIPO Watch & Free Growth Oriented Trading Recommendations - newser.com
Will breakout in NovaBay Pharmaceuticals Inc. lead to full recovery2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock outperform Dow JonesLong Setup & Fast Entry and Exit Trade Plans - newser.com
Heatmap analysis for NovaBay Pharmaceuticals Inc. and competitorsDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Why NovaBay Pharmaceuticals Inc. stock is trending among retail traders2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Is NovaBay Pharmaceuticals Inc. stock undervalued vs historical averagesWeekly Trade Review & Step-by-Step Trade Execution Guides - newser.com
What margin trends mean for NovaBay Pharmaceuticals Inc. stockWeekly Trend Summary & Target Return Focused Picks - newser.com
Is NovaBay Pharmaceuticals Inc. stock attractive for retirement portfoliosWeekly Trend Report & AI Enhanced Trading Alerts - newser.com
Is NovaBay Pharmaceuticals Inc. (B9P0) stock positioned for digital growth eraStop Loss & Technical Pattern Based Signals - newser.com
Is NovaBay Pharmaceuticals Inc. stock undervalued after correctionProduct Launch & Free Reliable Trade Execution Plans - newser.com
How analysts revise price targets for NovaBay Pharmaceuticals Inc. (B9P0) stock2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - newser.com
Statistical indicators supporting NovaBay Pharmaceuticals Inc.’s strengthQuarterly Trade Review & Safe Capital Investment Plans - newser.com
Is NovaBay Pharmaceuticals Inc. stock undervalued historicallyWeekly Volume Report & Weekly Market Pulse Updates - newser.com
What technical signals suggest for NovaBay Pharmaceuticals Inc. stockJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
Is NovaBay Pharmaceuticals Inc. (B9P0) stock a top dividend aristocrat candidateMarket Movement Recap & Community Driven Trade Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. stock withstand economic slowdownQuarterly Portfolio Summary & AI Enhanced Execution Alerts - newser.com
Published on: 2025-10-31 05:01:56 - newser.com
Published on: 2025-10-31 04:04:18 - newser.com
Published on: 2025-10-31 00:58:47 - newser.com
Can NovaBay Pharmaceuticals Inc. stock beat analyst consensus2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Novabay Pharmaceuticals Inc (NBY) 財務データ
収益
当期純利益
現金流量
EPS
0.64%
0.35%
大文字化:
|
ボリューム (24 時間):